TY - JOUR
AU1 - Baker, Danial E.
AB - Hospital Pharmacy Volume 40, Number 8, p 642 2005 Wolters Kluwer Health, Inc. Editorial Danial E. Baker, PharmD, FASCP FASHP* ave you ever watched a ucts (eg, albuterol, fluticasone, flu- the demand; patient activate a nisolide, cromolyn, nedocromil, • patients who require the product metered-dose inhaler ipratropium, and atropine) that are adequately served; and (MDI) that contains were classified as being exempt to • Health and Human Services/ chlorofluorocarbon (CFC) and these agreements, because the use FDA initiated notice of the pro- wondered if it just impacted the of the ODS in their formulation posed ruling and received public ozone layer and your risk of skin was considered essential. That list comments. cancer? If not, others have. Over will soon (in regulatory terms) The FDA has now satisfied all the past few years, the pharmaceu- have one less agent, the FDA has of these requirements, and tical industry has been developing announced its final ruling that albuterol will be removed from the alternative propellants for use in albuterol MDIs will no longer be “essential use” list for CFCs. The the MDI or dry-powder inhalation included on the CFC’s “essential pharmaceutical industry and the devices in order to comply with 
TI - Metered-Dose Inhalers and the Ozone Layer: 
JF - Hospital Pharmacy
DO - 10.1177/001857870504000801
DA - 2017-07-20
UR - https://www.deepdyve.com/lp/sage/metered-dose-inhalers-and-the-ozone-layer-MonauKWWz7
SP - 642
EP - 642
VL - 40
IS - 8
DP - DeepDyve
ER -